Phathom Pharmaceuticals, Inc. (PHAT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.21B |
| Enterprise Value | 1.29B |
| P/E Ratio | -6.1 |
| PEG Ratio | -0.04 |
| Price/Sales Ratio | 1.86 |
| Price/Book Ratio | 0 |
| Enterprise/Revenue | 1.8 |
| Enterprise/EBITDA | -24.92 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -0.3 |
| Operating Margin | -0.09 |
| Return On Assets | -0.24 |
| Return On Equity | 0.3 |
| Revenue | 175.11M |
| Revenue/Share | 3.24 |
| Gross Profit | 152.51M |
| EBITDA | -152.5M |
| Net Income | -221.25M |
| Diluted EPS | -3.03 |
| Total Cash | 184.56M |
| Total Cash/Share | 2.17 |
| Total Debt | 167.96M |
| Total Debt/Equity | 0 |
| Current Ratio | 1.76 |
| Book Value Per Share | -4.1 |
| 52-Week Change | -57.05 |
| 52-Week High | 18.31 |
| 52-Week Low | 5.01 |
| Moving Average 50 Days | 7.15 |
| Moving Average 200 Days | 10.14 |
| Average Volume | 1.44M |
| Shares Outstanding | 81.29M |
| % Held by Institutions | 86.56 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |